325 related articles for article (PubMed ID: 9850087)
21. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
22. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
Chen XQ; Wang WL; Huang GS
Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
[TBL] [Abstract][Full Text] [Related]
23. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
24. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of heat shock proteins in esophageal squamous cell carcinoma].
Chen JH; Chen LM; Xu LY; Wu MY; Shen ZY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):758-61. PubMed ID: 17366788
[TBL] [Abstract][Full Text] [Related]
26. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.
Sinkovics JG
Crit Rev Immunol; 1991; 11(1):33-63. PubMed ID: 1652972
[TBL] [Abstract][Full Text] [Related]
29. ICAM-3 expression on endothelium in lymphoid malignancy.
Doussis-Anagnostopoulou I; Kaklamanis L; Cordell J; Jones M; Turley H; Pulford K; Simmons D; Mason D; Gatter K
Am J Pathol; 1993 Oct; 143(4):1040-3. PubMed ID: 8214000
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical demonstration of cathepsin B in the macrophages of benign and malignant lymphoid tissues.
Crocker J; Burnett D; Jones EL
J Pathol; 1984 Jan; 142(1):87-94. PubMed ID: 6366177
[TBL] [Abstract][Full Text] [Related]
31. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
32. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production.
Pignatelli D; Ferreira J; Soares P; Costa MJ; Magalhães MC
Microsc Res Tech; 2003 Jun; 61(3):315-23. PubMed ID: 12768547
[TBL] [Abstract][Full Text] [Related]
34. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
35. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
[TBL] [Abstract][Full Text] [Related]
36. Heat shock protein 27 is expressed in normal and malignant human melanocytes in vivo.
Kang SH; Fung MA; Gandour-Edwards R; Reilly D; Dizon T; Grahn J; Isseroff RR
J Cutan Pathol; 2004 Nov; 31(10):665-71. PubMed ID: 15491326
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
[TBL] [Abstract][Full Text] [Related]
38. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase.
Cappello F; David S; Rappa F; Bucchieri F; Marasà L; Bartolotta TE; Farina F; Zummo G
BMC Cancer; 2005 Oct; 5():139. PubMed ID: 16253146
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomas.
Birgersdotter A; Baumforth KR; Wei W; Murray PG; Sjöberg J; Björkholm M; Porwit A; Ernberg I
Am J Clin Pathol; 2010 Feb; 133(2):271-80. PubMed ID: 20093237
[TBL] [Abstract][Full Text] [Related]
40. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]